EUVIMEDEUVIMED entdecken
Vergleichsstudie

Evaluation of cilnidipine-loaded self-micro-emulsifying drug delivery system (SMEDDS) by quantification of comparative pharmacokinetic parameters using validated LC-ESI-MS/MS bioanalytical method and pharmacodynamic assessment

Kumar Anand, Pallab Mandal, Samit Karmakar, Rudranil Bhowmik, Md Adil Shaharyar, Avishek Mandal, Arnab Sarkar, Akash De, Soumya Chakraborty, Subhabrata Ray, Manas Bhowmik, Sanmoy Karmakar

Annales Pharmaceutiques Françaises · 2024

DOI: 10.1016/j.pharma.2024.07.007 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annales Pharmaceutiques Françaises, 2024. Verfasst von Kumar Anand und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, West Bengal, India. Hauptthemen laut MEDLINE: Dihydropyridines, Tandem Mass Spectrometry, Calcium Channel Blockers, Drug Delivery Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Regardless of having desired therapeutic properties many of the recently approved drugs are removed from the developmental pipeline for their clinical use due to low solubility and permeability. Conventional dosage forms are found relatively unsuitable for achieving desired pharmacokinetic and pharmacodynamics profiles. Cilnidipine is 1,4 dihydropyridine derivative calcium channel blocker used for the treatment of hypertension. METHOD: The aim and objective of this study was to develop a precise and significant method in LC-MS/MS for quantification of pharmacokinetic parameters of a cilnidipine-loaded self-micro-emulsifying drug delivery system in rat plasma and simultaneously assessed pharmacodynamic characters in comparison with the marketed cilnidipine tablet. Another potential aim of this study is to reduce the dose of the drug in order to counter the dose-dependent toxicities related to chronic use. In the present study, the parent and product ion of cilnidipine was m/z 491.3\237.1. RESULT: The plasma was extracted by protein precipitation technique. The calibration standard concentrations were 1.875, 3.75, 7.50, 15.00, 30.00, 60.00ng/mL and LLOQ, low-quality control, middle-quality control and high-quality control were 1.87, 5.62, 22.50, 45.00ng/mL, respectively. The mobile phase composition was 0.1% formic acid in Milli Q water with 10mM Ammonium acetate as an aqueous solvent and 0.1% formic acid in methanol as an organic solvent. Following oral administration of optimized formulation Cmax (peak plasma concentration) was achieved 21.02±3.17ng/mL at 0.866±0.11h (Tmax), whereas in the case of marketed tablet Cmax (peak plasma concentration) was achieved 10.16±0.89ng/mL at 0.93±0.11h (Tmax). DISCUSSION: The in-vivo characterizations of the optimized SMEDDS showed significantly better pharmacokinetic parameters in Wistar rats and showed almost 2.4 times enhanced relative bioavailability as compared to the marketed tablet of cilnidipine which was observed to be correlating to our findings with noninvasive blood pressure parameter of Wistar rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DihydropyridinesTandem Mass SpectrometryCalcium Channel BlockersDrug Delivery SystemsEmulsionsAnimalsRatsMaleChromatography, LiquidSpectrometry, Mass, Electrospray IonizationReproducibility of ResultsRats, WistarAntihypertensive Agents

Stichwörter der Autor:innen

BCS class IIBCS classe IIBioavailabilityBiodisponibilitéCilnidipineLCMS/MSNIBPRats WistarSMEDDSTriacetinTriacétineWistar rats

Substanzen

DihydropyridinescilnidipineCalcium Channel BlockersEmulsionsAntihypertensive Agents

Autor:innen und Institutionen

  • Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, West Bengal, India.
  • Medical College, Kolkata, West Bengal, India. Electronic address: samitkarmakar2015@gmail.com.
  • Dr. B.C. Roy College of Pharmacy and Allied Health Sciences, Dr. Meghnad Saha Sarani, Bidhan Nagar, Durgapur 713206, India.
  • Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, West Bengal, India. Electronic address: sanmoykarmakar@gmail.com.

Zitieren

APA

Anand, K., Mandal, P., Karmakar, S., Bhowmik, R., Shaharyar, M. A., Mandal, A., Sarkar, A., De, A., Chakraborty, S., Ray, S., Bhowmik, M., & Karmakar, S. (2024). Evaluation of cilnidipine-loaded self-micro-emulsifying drug delivery system (SMEDDS) by quantification of comparative pharmacokinetic parameters using validated LC-ESI-MS/MS bioanalytical method and pharmacodynamic assessment. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2024.07.007

Vancouver

Anand K, Mandal P, Karmakar S, Bhowmik R, Shaharyar MA, Mandal A, et al. Evaluation of cilnidipine-loaded self-micro-emulsifying drug delivery system (SMEDDS) by quantification of comparative pharmacokinetic parameters using validated LC-ESI-MS/MS bioanalytical method and pharmacodynamic assessment. Annales Pharmaceutiques Françaises. 2024. doi:10.1016/j.pharma.2024.07.007

BibTeX
@article{Anand2024,
  author = {Anand, Kumar and Mandal, Pallab and Karmakar, Samit and Bhowmik, Rudranil and Shaharyar, Md Adil and Mandal, Avishek and Sarkar, Arnab and De, Akash and Chakraborty, Soumya and Ray, Subhabrata and Bhowmik, Manas and Karmakar, Sanmoy},
  title = {Evaluation of cilnidipine-loaded self-micro-emulsifying drug delivery system (SMEDDS) by quantification of comparative pharmacokinetic parameters using validated LC-ESI-MS/MS bioanalytical method and pharmacodynamic assessment},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2024},
  doi = {10.1016/j.pharma.2024.07.007}
}
Kostenlos starten →